Parameter | TNFAIP3 | p | ||
---|---|---|---|---|
T/T (n = 78) | G/T (n = 24) | G/G (n = 3) | ||
Age | 41.0c ±10.15 | 42.63c ±10.64 | 60.0ab ±8.66 | 0.008* |
DD | 4.74 ±5.09 | 3.75 ±2.14 | 7.67 ±4.04 | 0.329 |
ESR (1st hr.) | 46.88b ±23.93 | 85.75a ±42.51 | 66.0 ±6.93 | < 0.001* |
CRP (mg/l) | 24.62 ±19.50 | 26.40 ±17.99 | 14.12 ±13.75 | 0.574 |
RF (IU/ml) | 15.05 (7.0-359.0) | 18.75 (8.0-189.0) | 27.0 (27.0-41.20) | 0.285 |
Anti-CCP (U/ml) | 64.59b ±48.14 | 95.34a ±59.73 | 80.87 ±81.87 | 0.042* |
Disease activity score (DAS28) | 4.38b ±0.94 | 5.20a ±0.78 | 5.24 ±0.45 | < 0.001* |
Tender joints count | 7.44b ±5.36 | 10.0a ±5.11 | 4.67 ±1.15 | 0.066 |
Swollen joints count | 1.77c ±1.35 | 2.75c ±3.67 | 8.0ab ±5.20 | < 0.001* |
Normally quantitative data are expressed as mean ± SD and compared using F test (ANOVA), while abnormally quantitative data are expressed as median (min. – max.) and compared using Kruskal Wallis test
significant with T/T
significant with G/T
significant with G/G
statistically significant at p ≤ 0.05